Replies to post #705309 on NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

First icnolights awesome math skills.

29000 X 9 X .69 = 180,090
29000 X 9 X .40 = 104,400

Danish Dude's incredible investing = -75,690

Remind me again how many pre-biotechs you've been invested in?

Ahh ... NON invested in! That's right. You're just a part of the rare dirty dozen of philantropic Florence Nightingalers specie, who worries on behalf of retailers 24/7, or rather worries about them bagholding the shares, their masters so very much would like to get their hands on.

Let's start in kinder school ... little icnolight ... come sit up front!

In finance, an investment is a financial asset bought with the idea that the asset will provide income further or will later be sold at a higher cost price for a profit.

Did you notice the word "later"?

The trick - icnofuckinglightatall - is not minding the manipulation.



That a dozen of paid shills on this board acts as stand-in for retailers, in a way that must resemble being late to the rescue boats on Titanic day in day out ... well, that's mighty polite by you, that you lot care so much for us "being down".

But ... and here is lesson number two.

"It was never my thinking that made the big money for me. It always was my sitting. Got that? My sitting tight!"

This contains decades of experience with the stock market, turning Jessie Livermore into a very succesful investor.

A sentiment which Warren Buffet shared

"The stock market is designed to transfer money from the Active to the Patient."

And Charlie Munger

"The big money is not in the buying and the selling, but in the waiting."

So while you - curiously enough, non invested in NWBO - people, are sharing your scripted tantrums with us here daily ... thanks for you concern, but averaging down is the art of continously adding shares at lower prices, thus lowering the average price pr. share.

That equation is 29.000 at $1.30 and now 269.000 at $0.69.

Not having sold, you will see, that I still own 269.000 shares. Since I have not sold any during the time I have been invested, I neither collected a loss nor win, because thats the case, with investing in pre-revenue biotechs.

It's kind of a better deal to wait with the selling, till the pre-revenue biotechs become revenue biotechs.

The case for bagholding.

Wouldn't you say that was correct? If you look past the transscript received by ... is it Ken Griffin or Midwest Hedgie Chris Brown?

The stock for this company hit $0.14 at one time. And people still bought.

jon_k84 made a fine sum up of your scam:

DC-VAX is not real, it's a scam company.
-Ok, it's a real company, but DC-Vax doesn't work.
-OK, DC-Vax might work, but the trial is badly designed and statistical analysis plan will never get accepted.
-OK, SAP got accepted, but they'll never release top line data.
-OK, they'll release top line data, but a journal will never publish it.
-OK, a journal might publish it, but not top-tier.
-OK, a top-tier journal published it, but some major doctors dissented and they will never get a regulatory application out.
-OK, they got the regulatory application out, but it won't be accepted.
-OK, the regulatory application to the MHRA was accepted, but it'll never get approved.

Add to that the best state of the art dendritic cells automation and scaling device on the market, enabling lowering of cost and quick manufactoring of doses. Patented IP globally. One 14 year long combo trial with results published in Nature and one with Keytruda at UCLA nearing its primary completion date. And a british report two years in the making, regarding Britains efforts on glioblastoma including top priority of getting MHRA to approve and NICE to reimburse DCVax-L.

captain: we don't have to wonder why the share price falls every day - nwbo sells 1 million shares per trading day. yesterday, with 1.8 million shares traded, that was over 60% of total turnover ... the fact that LP claims we don't understand why the share price is so low is simply not the truth

Share price was $2.51 at data lock. 7 fat milestones later and with approval upcoming, we trade at $0.39

Now, would you please help me with the math you are doing here?

We were around 800M shares at data lock.

We are around 1.23B shares currently.

That is 53.75% rise.

From $2.51 to $0.39.

A decline of 84.46%

Let's ask ChatGBT

If we have 800 million shares outstanding at $2.51 a piece and we 4 years later have 1.23 billion shares outstanding at $0.39 a piece, can you explain to me if that share price - all things even - is fluctuating with the old share price in relation to outstanding shares? If not, what should the share price be today?

Answer

The current share price of $0.39 indicates that the company's market capitalization has decreased significantly. If the market capitalization had stayed the same, the share price should be around $1.63, given the increase in shares outstanding to 1.23 billion. Therefore, the current share price does not fluctuate in a manner consistent with maintaining the same market capitalization.

So $1.63 would have been the share price correlating with the old one. If we take $1.81 instead it would have to be around 1.18 We're talking 3-4 times $0.39.

And that is AFTER 7 fat milestones.

Your statement

"the fact that LP claims we don't understand why the share price is so low is simply not the truth"

is so off chart considering what are the factual circumstances regarding the share price of NWBO.

So please tell me, why you leave out the lawsuit and spoofing in the equation?

You ARE aware, that if the share price was not spoofed and the share price actually DID reflect the milestones reached, we could have had around $80M shares in dilution securing the company the same revenue to do their business instead of $430M?

There you have your truth.

How is it possible for retailers on this board to be so way off basic, elementary stuff regarding what hurts the share price?

Don't answer. It was rhetorical.